Los Angeles Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Sell |
11,685
-9,243
| -44% | -$526K | ﹤0.01% | 777 |
|
|
2025
Q1 | $1.17M | Sell |
20,928
-2,750
| -12% | -$154K | 0.01% | 525 |
|
|
2024
Q4 | $1.46M | Sell |
23,678
-6,875
| -23% | -$423K | 0.01% | 515 |
|
|
2024
Q3 | $2.04M | Sell |
30,553
-2,730
| -8% | -$183K | 0.01% | 455 |
|
|
2024
Q2 | $2.22M | Buy |
33,283
+20,197
| +154% | +$1.35M | 0.01% | 429 |
|
|
2024
Q1 | $931K | Buy |
13,086
+7,320
| +127% | +$521K | ﹤0.01% | 717 |
|
|
2023
Q4 | $486K | Hold |
5,766
| – | – | ﹤0.01% | 879 |
|
|
2023
Q3 | $496K | Buy |
5,766
+53
| +0.9% | +$4.56K | ﹤0.01% | 826 |
|
|
2023
Q2 | $532K | Buy |
5,713
+451
| +9% | +$42K | ﹤0.01% | 837 |
|
|
2023
Q1 | $499K | Sell |
5,262
-275
| -5% | -$26.1K | ﹤0.01% | 854 |
|
|
2022
Q4 | $557K | Hold |
5,537
| – | – | ﹤0.01% | 865 |
|
|
2022
Q3 | $472K | Hold |
5,537
| – | – | ﹤0.01% | 941 |
|
|
2022
Q2 | $476K | Buy |
5,537
+1,849
| +50% | +$159K | ﹤0.01% | 984 |
|
|
2022
Q1 | $331K | Hold |
3,688
| – | – | ﹤0.01% | 1207 |
|
|
2021
Q4 | $369K | Hold |
3,688
| – | – | ﹤0.01% | 1151 |
|
|
2021
Q3 | $342K | Sell |
3,688
-450
| -11% | -$41.7K | ﹤0.01% | 1245 |
|
|
2021
Q2 | $352K | Hold |
4,138
| – | – | ﹤0.01% | 1329 |
|
|
2021
Q1 | $358K | Buy |
4,138
+1,191
| +40% | +$103K | ﹤0.01% | 1368 |
|
|
2020
Q4 | $248K | Hold |
2,947
| – | – | ﹤0.01% | 1428 |
|
|
2020
Q3 | $235K | Buy |
2,947
+282
| +11% | +$22.5K | ﹤0.01% | 1351 |
|
|
2020
Q2 | $236K | Buy |
+2,665
| New | +$236K | ﹤0.01% | 1354 |
|